DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 160 filers reported holding DIPLOMAT PHARMACY INC in Q4 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $300,000 | +971.4% | 75,000 | +1174.2% | 0.00% | – |
| Q3 2019 | $28,000 | -90.0% | 5,886 | -87.3% | 0.00% | -100.0% |
| Q2 2019 | $281,000 | +83.7% | 46,233 | +75.5% | 0.00% | – |
| Q1 2019 | $153,000 | -77.9% | 26,340 | -26.2% | 0.00% | -100.0% |
| Q3 2018 | $693,000 | +231.6% | 35,711 | +244.3% | 0.00% | -77.8% |
| Q1 2018 | $209,000 | -27.4% | 10,373 | -27.9% | 0.01% | -25.0% |
| Q4 2017 | $288,000 | +476.0% | 14,387 | +354.4% | 0.01% | +500.0% |
| Q1 2017 | $50,000 | +4900.0% | 3,166 | +2298.5% | 0.00% | – |
| Q4 2016 | $1,000 | -97.6% | 132 | -91.2% | 0.00% | -100.0% |
| Q3 2016 | $42,000 | -76.3% | 1,503 | -76.8% | 0.00% | -78.6% |
| Q1 2016 | $177,000 | -66.5% | 6,473 | -58.1% | 0.01% | -65.9% |
| Q4 2015 | $528,000 | +1408.6% | 15,443 | +1160.7% | 0.04% | +1266.7% |
| Q3 2015 | $35,000 | -52.1% | 1,225 | -25.4% | 0.00% | -50.0% |
| Q2 2015 | $73,000 | – | 1,642 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |